Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With Diabetes

NCT01520818 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

666

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2

Interventions

DRUG: biphasic insulin aspart 50
DRUG: biphasic insulin aspart 70
DRUG: biphasic human insulin 30

Sponsor

Novo Nordisk A/S